Scientists discuss the body of literature suggesting that ceramides are drivers — and not merely passengers — on the road to cardiovascular disease.
[Nature Reviews Cardiology]
6445218
{6445218:ZBW7UH2U}
apa
50
1
160584
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-cd4124e500f089d713074d9d1200e98c%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZBW7UH2U%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Choi%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EChoi%2C%20R.%20H.%2C%20Tatum%2C%20S.%20M.%2C%20Symons%2C%20J.%20D.%2C%20Summers%2C%20S.%20A.%2C%20%26amp%3B%20Holland%2C%20W.%20L.%20%282021%29.%20Ceramides%20and%20other%20sphingolipids%20as%20drivers%20of%20cardiovascular%20disease.%20%3Ci%3ENature%20Reviews%20Cardiology%3C%5C%2Fi%3E%2C%201%26%23x2013%3B11.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41569-021-00536-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41569-021-00536-1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DZBW7UH2U%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ceramides%20and%20other%20sphingolipids%20as%20drivers%20of%20cardiovascular%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%20Hee%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20M.%22%2C%22lastName%22%3A%22Tatum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20David%22%2C%22lastName%22%3A%22Symons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20A.%22%2C%22lastName%22%3A%22Summers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20L.%22%2C%22lastName%22%3A%22Holland%22%7D%5D%2C%22abstractNote%22%3A%22Increases%20in%20calorie%20consumption%20and%20sedentary%20lifestyles%20are%20fuelling%20a%20global%20pandemic%20of%20cardiometabolic%20diseases%2C%20including%20coronary%20artery%20disease%2C%20diabetes%20mellitus%2C%20cardiomyopathy%20and%20heart%20failure.%20These%20lifestyle%20factors%2C%20when%20combined%20with%20genetic%20predispositions%2C%20increase%20the%20levels%20of%20circulating%20lipids%2C%20which%20can%20accumulate%20in%20non-adipose%20tissues%2C%20including%20blood%20vessel%20walls%20and%20the%20heart.%20The%20metabolism%20of%20these%20lipids%20produces%20bioactive%20intermediates%20that%20disrupt%20cellular%20function%20and%20survival.%20A%20compelling%20body%20of%20evidence%20suggests%20that%20sphingolipids%2C%20such%20as%20ceramides%2C%20account%20for%20much%20of%20the%20tissue%20damage%20in%20these%20cardiometabolic%20diseases.%20In%20humans%2C%20serum%20ceramide%20levels%20are%20proving%20to%20be%20accurate%20biomarkers%20of%20adverse%20cardiovascular%20disease%20outcomes.%20In%20mice%20and%20rats%2C%20pharmacological%20inhibition%20or%20depletion%20of%20enzymes%20driving%20de%20novo%20ceramide%20synthesis%20prevents%20the%20development%20of%20diabetes%2C%20atherosclerosis%2C%20hypertension%20and%20heart%20failure.%20In%20cultured%20cells%20and%20isolated%20tissues%2C%20ceramides%20perturb%20mitochondrial%20function%2C%20block%20fuel%20usage%2C%20disrupt%20vasodilatation%20and%20promote%20apoptosis.%20In%20this%20Review%2C%20we%20discuss%20the%20body%20of%20literature%20suggesting%20that%20ceramides%20are%20drivers%20%5Cu2014%20and%20not%20merely%20passengers%20%5Cu2014%20on%20the%20road%20to%20cardiovascular%20disease.%20Moreover%2C%20we%20explore%20the%20feasibility%20of%20therapeutic%20strategies%20to%20lower%20ceramide%20levels%20to%20improve%20cardiovascular%20health.%22%2C%22date%22%3A%222021-03-26%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41569-021-00536-1%22%2C%22ISSN%22%3A%221759-5010%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41569-021-00536-1%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-03-26T22%3A01%3A59Z%22%7D%7D%5D%7D
Choi, R. H., Tatum, S. M., Symons, J. D., Summers, S. A., & Holland, W. L. (2021). Ceramides and other sphingolipids as drivers of cardiovascular disease. Nature Reviews Cardiology, 1–11. https://doi.org/10.1038/s41569-021-00536-1 Cite
